| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.08 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.084 | 0.08 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.09 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |